474 related articles for article (PubMed ID: 23647412)
21. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
Kahl-McDonagh MM; Ficht TA
Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
[TBL] [Abstract][Full Text] [Related]
23. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
[TBL] [Abstract][Full Text] [Related]
24. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
[TBL] [Abstract][Full Text] [Related]
26. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
27. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
28.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
30. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
[TBL] [Abstract][Full Text] [Related]
31. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
33. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
[TBL] [Abstract][Full Text] [Related]
34. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
35. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
36. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
[TBL] [Abstract][Full Text] [Related]
37. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
Truong QL; Cho Y; Kim K; Park BK; Hahn TW
Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
[TBL] [Abstract][Full Text] [Related]
38. Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
Adone R; Ciuchini F; Marianelli C; Tarantino M; Pistoia C; Marcon G; Petrucci P; Francia M; Riccardi G; Pasquali P
Infect Immun; 2005 Jul; 73(7):4198-204. PubMed ID: 15972510
[TBL] [Abstract][Full Text] [Related]
39. Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.
Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Rice-Ficht AC
Infect Immun; 2008 Jun; 76(6):2448-55. PubMed ID: 18362129
[TBL] [Abstract][Full Text] [Related]
40. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
